"We obviously still need to manage the short-term challenges but, as an industry, we have to show leadership on the future and working with the government to ensure Australian patients are in a position to access these new technologies," says Novartis' Lauren Carey.
Lauren Carey: Review a 'great opportunity' to shape future
September 18, 2019 Latest NewsBioPharmaDispatch ExecutiveLatest Video
New Stories
-
Stakeholders force Pharmac backdown on move to scrap childhood cancer access program
March 19, 2024 - - Latest News -
ViiV Healthcare Australia announces recipients of 2023 Positive Action Community Grants 
March 19, 2024 - - Latest News -
'I'm a big believer that we as public servants need to engage honestly with our stakeholders'
March 19, 2024 - - Latest News -
A misguided response disconnected from its own history and reality
March 18, 2024 - - Latest News -
Where are the stewards to maintain and protect this critical public health program?
March 18, 2024 - - Latest News -
The fast-finishing AstraZeneca secures Pharma Cup for 2024 Kosi Challenge
March 18, 2024 - - Latest News -
Merck expands fertility benefit for its employees in Australia
March 15, 2024 - - Latest News